Bioactive by-products

It is produced by the strain of Actinomadura sp. No. SA-4427. It has anti-mycoplasma and anti-tumor effects.

It is produced by the strain of Bacillus aminoglucosidicus. It has the activity of resistant bacillus subtilis and other gram-positive bacteria.

It is produced by the strain of Streptomyces sp. It can inactivate many vitamin B6-enzymes, such as Cystathionine γ-synthase, Methionone γ-lyase and L-alanine aminotransferase.

Cytosporin B is a minor component produced by Cytospora sp.

Cytosporin C is a minor component produced by Cytospora sp.

Dactylocycline is a tetracycline antibiotic produced by Dactylospoangium sp.. Dactylocycline B has anti-Gram-positive bacteria and weak anti-Gram-negative bacteria activity, and is not cross-resistant with tetracycline-resistant bacteria.

Dactylocycline is a tetracycline antibiotic produced by Dactylospoangium sp.. Dactylocycline D has anti-Gram-positive bacteria activity.

Dactylocycline is a tetracycline antibiotic produced by Dactylospoangium sp.. Dactylocycline E has anti-Gram-positive bacteria activity.

Decarestrictin M is a cholesterol biosynthesis inhibitor produced by Penicillum sunplicissimum and Pen. corylophilufn.

Flavidulol A is an antibiotic produced by Lactarius flavidula. Flavidulol B is the Cope rearrangement product of Flavidulol A.

Flavidulol C is a compound produced by Lactarius flavidula.

Flavidulol A is an antibiotic produced by Lactarius flavidula. Flavidulol D is the stearate of Flavidulol A.

It is produced by the strain of Crinipellis stipitaria. It has anti-gram-positive bacteria and Aldrin ascites carcinoma activity.

It is produced by the strain of Crinipellis stipitaria. It has anti-gram-positive bacteria and Aldrin ascites carcinoma activity.

It is produced by the strain of Crinipellis stipitaria. It has anti-gram-positive bacteria and Aldrin ascites carcinoma activity.

It is produced by the strain of Streptomyces sp. HKI 0180. It has a moderate level of activity against gram-positive bacteria, Its MIC against Staphylococcus aureus and Bacillus subtilis is greater than 50 μg/mL.

It is produced by the strain of Streptomyces sp. HKI 0180. It has a moderate level of activity against gram-positive bacteria, Its MIC against Staphylococcus aureus and Bacillus subtilis is greater than 50 μg/mL.

It is produced by the strain of Streptomyces sp. K749-42. It is an amino acid that has antifungal properties. It has anti-candida albicans effect. Its activity is similar to Cispentacin.

It is produced by the strain of Micromonospora sp. A92-313709. Cymbimicin A had a strong affinity with cyclosporin-binding protein, and the affinity between Cymbimicin B and cyclosporin-binding protein was about 100 times lower than that of Cymbimicin A.

It is produced by the strain of Micromonospora sp. A92-313709. Cymbimicin B had a strong affinity with cyclosporin-binding protein, and the affinity between Cymbimicin B and cyclosporin-binding protein was about 100 times lower than that of Cymbimicin A.